[Severe bradyarrhythmia during myocardial perfusion scintigraphy with injection of dipyridamole (Persantine)].
We describe two cases of severe bradyarrhythmias (one complete AV dissociation; one sinus bradycardia) observed after the intravenous injection of dipyridamole.
Bielen
M
M
Service de Cardiologie, Université de Liège.
Karsera
D
D
Mélon
P
P
Kulbertus
H
H
D000368:Aged; D001146:Arrhythmia, Sinus / Q000139:chemically induced*; D001919:Bradycardia / Q000139:chemically induced*; D004176:Dipyridamole / Q000008:administration & dosage / Q000009:adverse effects*; D004562:Electrocardiography / Q000187:drug effects; D005260:Female; D006321:Heart / Q000000981:diagnostic imaging*; D006327:Heart Block / Q000139:chemically induced; D006801:Humans; D007022:Hypotension / Q000139:chemically induced; D007262:Infusions, Intravenous; D008297:Male; D008875:Middle Aged; D011877:Radionuclide Imaging; D019275:Radiopharmaceuticals; D017256:Technetium Tc 99m Sestamibi; D014665:Vasodilator Agents / Q000008:administration & dosage / Q000009:adverse effects*
D019275:Radiopharmaceuticals; D014665:Vasodilator Agents; D004176:Dipyridamole; D017256:Technetium Tc 99m Sestamibi